文献速递心脑血管急症重症综合管理与镇静镇痛

院外心脏骤停后目标温度管理32-34°C对区域脑氧饱和度分层患者的影响:多中心回顾性队列研究

Effect of target temperature management at 32-34 °C in cardiac arrest patients considering assessment by regional cerebral oxygen saturation: A multicenter retrospective cohort study.
PubMed 文献 · Resuscitation · 2018-02-09
一句话结论院外心脏骤停昏迷患者入院时区域脑氧饱和度41-60%者,32-34°C目标温度管理可降低90天全因死亡率并改善神经功能预后。

本研究为日本15家医院2011至2013年前瞻性登记数据的二次分析,纳入院外心脏骤停后昏迷患者431例,按入院时区域脑氧饱和度(rSO2)分为≤40%(n=296)、41-60%(n=67)、≥61%(n=68)三组。倾向性评分分析显示,32-34°C目标温度管理使rSO2 41-60%组90天全因死亡率降低(PSM的ATT -0.51,95%CI -0.70至-0.33;IPW的ATT -0.52,95%CI -0.71至-0.34),并提高该组神经功能良好预后(PSM的ATT 0.50,95%CI 0.32-0.68;IPW的ATT 0.52,95%CI 0.35-0.69)。rSO2≤40%和≥61%组未见上述效应。

要点

  • 入院时rSO2 41-60%的院外心脏骤停昏迷患者,32-34°C目标温度管理降低90天全因死亡率(PSM的ATT -0.51,95%CI -0.70至-0.33)。
  • 同一rSO2 41-60%组,32-34°C目标温度管理提高神经功能良好预后(PSM的ATT 0.50,95%CI 0.32-0.68)。
  • rSO2≤40%组(n=296)和rSO2≥61%组(n=68)未报告32-34°C目标温度管理的显著获益。
  • rSO2通过近红外光谱无创监测,可评估脑灌注及氧输送与摄取平衡。
  • 研究为日本15家医院的多中心回顾性队列二次分析,结论需结合原文局限解读。

适用人群与场景

  • 日本15家医院2011至2013年收治的院外心脏骤停后昏迷患者,共431例。
  • 按入院时区域脑氧饱和度分层:≤40%(n=296)、41-60%(n=67)、≥61%(n=68)。

诊断标准与关键阈值

  • 区域脑氧饱和度(rSO2)通过近红外光谱无创监测,按入院时数值分为≤40%、41-60%、≥61%三组。

处置流程与药物剂量

  • 对入院时rSO2 41-60%的院外心脏骤停昏迷患者实施32-34°C目标温度管理。

研究设计与关键结果

  • 研究类型为多中心回顾性队列研究(前瞻性登记数据的二次分析),样本量431例,来自日本15家医院。
  • 主要终点为院外心脏骤停后90天全因死亡率;次要终点为按脑功能分类评估的神经功能良好预后。
  • rSO2 41-60%组:32-34°C目标温度管理降低90天全因死亡率(PSM的ATT -0.51,95%CI -0.70至-0.33;IPW的ATT -0.52,95%CI -0.71至-0.34)。
  • rSO2 41-60%组:32-34°C目标温度管理提高神经功能良好预后(PSM的ATT 0.50,95%CI 0.32-0.68;IPW的ATT 0.52,95%CI 0.35-0.69)。
  • rSO2≤40%组和rSO2≥61%组未报告32-34°C目标温度管理的显著效应。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究(前瞻性收集登记数据的二次分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对院外心脏骤停后昏迷患者,入院时可使用近红外光谱无创监测rSO2,按41-60%分层识别可能从32-34°C目标温度管理获益的人群。
  • 作者结论认为,32-34°C目标温度管理可有效降低入院时rSO2 41-60%的院外心脏骤停昏迷患者的全因死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Target temperature management (TTM) is used in comatose post-cardiac arrest patients, but the recommended temperature range is wide. This study aimed to assess the effectiveness of TTM at 32-34 °C while considering the degree of cerebral injury and cerebral circulation, as assessed by regional cerebral oxygen saturation (rSO2).

METHODS: This is a secondary analysis of prospectively collected registry data from comatose patients who were transferred to 15 hospitals in Japan after out-of-hospital cardiac arrest (OHCA) from 2011 to 2013. The primary outcome was all-cause mortality at 90 days after OHCA, and the secondary outcome was favorable neurological outcomes as evaluated according to the Cerebral Performance Category. We monitored rSO2 noninvasively with near-infrared spectroscopy, which could assess cerebral perfusion and the balance of oxygen delivery and uptake.

RESULTS: We stratified 431 study patients into three groups according to rSO2 on hospital arrival: rSO2 ≤40% (n = 296), rSO2 41-60% (n = 67), and rSO2 ≥61% (n = 68). Propensity score analysis revealed that TTM at 32-34 °C decreased all-cause mortality in patients with rSO2 41-60% (average treatment effect on treated [ATT] by propensity score matching [PSM] -0.51, 95%CI -0.70 to -0.33; ATT by inverse probability of treatment weighting [IPW] -0.52, 95%CI -0.71 to -0.34), and increased favorable neurological outcomes in patients with rSO2 41-60% (ATT by PSM 0.50, 95%CI 0.32-0.68; ATT by IPW 0.52, 95%CI 0.35-0.69).

CONCLUSION: TTM at 32-34 °C effectively decreased all-cause mortality in comatose OHCA patients with rSO2 41-60% on hospital arrival in Japan.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Nakatani Y, Nakayama T, Nishiyama K, et al. Effect of target temperature management at 32-34 °C in cardiac arrest patients considering assessment by regional cerebral oxygen saturation: A multicenter retrospective cohort study. Resuscitation. 2018. PMID: 29432783. doi:10.1016/j.resuscitation.2018.02.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。